Schedule 13G ownership disclosure
Palvella Therapeutics Inc
Common Stock · CUSIP: 697947109
Event date: 2026-09-30
- Filing-level shares
- 1,101,652
- Percent of class
- 7.7%
- Jennison Associates LLC
Shares: 1,101,652 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-26-000064
- Form type
- SCHEDULE 13G/A
- Filer
- PALVELLA THERAPEUTICS, INC.
- CIK
- CIK 1583648
- Filed
- Oct 28, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership